BC047440 overexpression is a risk factor for tumor invasion and poor prognosis in hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 57, Issue 101, 2010, Pages 919-925

  Zheng, Lu ^a   Huang, Xiaobing ^a   Liang, Ping ^a   Wen, Yu ^b   Yang, Tonghan ^a   Li, Yan ^c   Zhao, HongZhi ^a   Han, KeQiang ^a   Li, Jing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Third People's Hospital of Chongqing   (China)

^c CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; Polyclonal antibody; Prognosis

Indexed keywords

POLYCLONAL ANTIBODY; PROTEIN BC 047440; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CANCER GROWTH; CANCER INVASION; CLINICAL FEATURE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RISK FACTOR; TUMOR VOLUME; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; RISK FACTORS;

EID: 78149231950     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Imamura Y, Sano H: International comparisons of cumulative risk of liver cancer,from Cancer Incidence in Five Continents Vol.Jpn J Clin Oncol. 2006; 36:259-260.
2. Ohta K, Ohigashi M, Naganawa A, Ikeda H, Sakai M, Nishikawa JI, Imagawa M, Osada S, Nishihara T: Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis. Biochem J. 2007; 40:2559-2566.
3. Kwon Y, Lee SK, Kim JS, Ro JY, Yu E: Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules, Mod Pathol. 2002; 15:1096-1101.
4. Shigehiro O, Ayako N, Masashi M, Soken T, Shigero T, Yasushi O, Jun-ichi N, Kimihiko S, Masayoshi I, Gozoh T, Yukihiko S and Tsutomu N: Altered gene expression of transcriptional regulatory factors in tumor marker-positive cells during chemically induced hepatocarcinogenesis. Toxicol Lett. 2006; 167:106-113.
5. Yeh SH, Chiu CM, Chen CL, Lu S, Hsu HC, Chen DS and Chen PJ: Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma.Int J Cancer. 2007; 1610-1617.
6. Li J, Han BL, Huang GJ, Qian GS, Liang P, Yang TH, Chen J: Screening and identification for cDNA of differentially expressed genes in human primary hepatocellular carcinoma.Chin J Med Genet. 2003; 20:49-51.
7. Zhao HZ, Li J, Liang P, Li HY, Huang XB: Molecular cloning and identification of a novel gene and its relationship to hepatocellular carcinoma. Chin J of Hepato. 2005; 13:483-483.
8. Zhou JB, Li J, Liang P, Yang TH, Huang XB: Primary study of the function of a novel gene BC047440 highly expressed in human hepatocellular carcinom.Chin J Exp Surg. 2006; 15:582-585.
9. Zheng L, Li J, Liang P, Yang TH, Huang XB, Liu SC: Expression of a new gene BC047440 in multiplicate malignant tumor tissues and its significance. Chin J of Gen Surg. 2008; 15:185-189.
10. Liu SC, Li J, Huang XB, Yang TH, Liang P, Zheng L, Zhao HZ: SiRNA-mediated Silencing of BC047440 Gene Inhibits Proliferation of Human HepG2 Cell And Initial Study Mechanism.BC047440-siRNA.Acta Acad Med Militaris Tertiae. 2007; 29: 2207-2211.
11. Kothari H, Kumar P, Singh N: Prokaryotic expression, purification,and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate, Protein Expr. Purif. 2006; 45:15-21.
12. Hochuli E, Bannwarth W, Dobeli H, Gentz R, Stuber D: Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate absorbentD. Bio Technology. 1988; 6:1321-1325.
13. Yang J, Guo SY, Pan FY, Geng HX, Gong Y, Lou D, Shu YQ: Prokaryotic expression and polyclonal antibody preparation of a novel Rab-hke protein mRabL5. Protein Expr. Purif. 2007; 56:1-7.
14. 5)μ-Conotoxin GIIIA Site-Specifically Conjugated with Bovine Serum Albumin. Biochem Bioph Res Co. 2002; 290:1037-1041.
15. Li JJ, Ding Y, Li DD, Peng RQ, Feng GK, Zeng YX, Zhu XF, Zhang XS: The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP. Cancer Biol Ther. 2009; 8(20):1914-1921.
16. Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma. J Hepatol. 2003; 38:591-597.
17. Feitelson MA, Lee J: Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett. 2007; 252:157-170.
18. Kuznecovs S, Kuznecovs I: OL-048 P-glycoprotein regulation in Hep3B cells by polyprenol could decrease the risk of hepatocarcinogenesis in HBV. Int J Infect Dis. 2009; 13:S45.
19. Zalatnai A, Sárosi I, Rot A, Lapsis K: Inhibitory and promoting effects of carbon tetrachloride-induced liver cirrhosis on the diethylnitrosamine hepatocarcinogenesis in rats. Cancer Lett. 1991; 57:67-73.
20. Hwang YH, Choi JY, Kim S, Chung ES, Kim T, Koh SS, Lee B, Bae SH, Kim J, Park YM: Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma.Hepatol Res. 2004; 29:113-121.
21. Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M: α-Fetoprotein, Des-y Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma. Gastroenterology. 2009; 137:110-118.
22. Abelev GI, Eraiser TL: Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin Cancer Biol. 1999; 9:95-107.
23. Debruyne EN, Delanghe JR: Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications. Clinica Chimica Acta. 2008, 395:19-26.
24. Faivre J, Forman D, Esteve J, Obradovic M, Sant M: Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer. 1998, 34:2184-2190.
25. Chen P-H, Lin Y-C, Tu H-P, Chiang S-L, Ko AM, Hsu C-L, Chang Y-F, Ko Y-C: Important prognostic factors for the long-term survival of subjects with primary liver cancer in Taiwan: A hyperendemic area. Eur J Cancer. 2007; 43:1076-1084.
26. Pignata S, Gallo C, Daniele B, Elba S, Giorgio A, Capuano G, Adinolfi LE, De Sio I, Izzo F, Farinati F, Del Naja C, Stanzione M, Castiglione F, Marone G, Cuomo O, Felder M, Gaeta GB, De Maio E, Di Maio M, Signoriello G: Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly: A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hemat. 2006; 59:243-249.